Marshall Wace
MBOT icon

Marshall Wace’s Microbot Medical MBOT Stock Holding History

Marshall Wace’s Portfolio MBOT Stock Details MBOT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.06M Buy
541,963
+60,918
+13% +$124K ﹤0.01% 2163
2026
Q1 		$1.16M Buy
+481,045
New +$1.07M ﹤0.01% 2063

Other funds holding MBOT

Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
DnB Asset Management
DnB Asset Management Oslo, Norway $35.7B AUM 27.58% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace's MBOT Position: Q2 2026 in Review

Marshall Wace increased its Microbot Medical (MBOT) stake by 13% in Q2 2026, buying an estimated $124K and bringing the position to 541,963 shares worth $1.06M. The position accounts for ﹤0.01% of the portfolio, ranked #2163.

Marshall Wace first reported a position in MBOT in Q1 2026 and has held it in 2 quarters since. The position peaked at $1.16M in Q1 2026. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Marshall Wace held 541,963 shares of Microbot Medical worth $1.06M as of Q2 2026.
  • Marshall Wace bought 60,918 Microbot Medical shares in Q2 2026, an estimated $124K.
  • Microbot Medical made up ﹤0.01% of Marshall Wace's portfolio in Q2 2026, its #2163 holding.
  • Marshall Wace first reported a position in Microbot Medical in Q1 2026 and has held it in 2 quarters since.
  • Marshall Wace's Microbot Medical position peaked at $1.16M in Q1 2026.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Marshall Wace's 13F filing for Q2 2026, filed 13 Aug 2026.